Skip NavigationSkip to Content
Return Return to Search Results

APOBEC affects tumor evolution and age at onset of lung cancer in smokers

  1. Author:
    Zhang, Tongwu [ORCID]
    Sang, Jian
    Hoang, Phuc H [ORCID]
    Zhao, Wei [ORCID]
    Rosenbaum, Jennifer
    Johnson, Kofi Ennu
    Klimczak, Leszek J [ORCID]
    McElderry, John
    Klein, Alyssa [ORCID]
    Wirth, Christopher [ORCID]
    Bergstrom, Erik N
    Díaz-Gay, Marcos [ORCID]
    Vangara, Raviteja [ORCID]
    Colon-Matos, Frank
    Hutchinson,Amy
    Lawrence,Scott [ORCID]
    Cole,Nathan
    Zhu, Bin [ORCID]
    Przytycka, Teresa M [ORCID]
    Shi, Jianxin [ORCID]
    Caporaso, Neil E
    Homer, Robert [ORCID]
    Pesatori, Angela C [ORCID]
    Consonni, Dario [ORCID]
    Imielinski, Marcin
    Chanock, Stephen J [ORCID]
    Wedge, David C [ORCID]
    Gordenin, Dmitry A [ORCID]
    Alexandrov, Ludmil B [ORCID]
    Harris, Reuben S [ORCID]
    Landi, Maria Teresa [ORCID]

  2. Author Address

    Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA., Westat, Rockville, MD, USA., New York Genome Center, New York, USA., Integrative Bioinformatics Support Group, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Manchester Cancer Research Centre, The University of Manchester, Manchester, UK., Department of Cellular and Molecular Medicine and Department of Bioengineering and Moores Cancer Center, University of California San Diego, La Jolla, CA, USA., Cancer Genomics Research Laboratory, Frederick National Laboratory for Cancer Research, Frederick, MD, USA., National Center for Biotechnology Information, National Library of Medicine, National Institutes of Health, Bethesda, MD, USA., Department of Pathology, Yale School of Medicine, New Haven, CT, USA., Department of Clinical Sciences and Community Health, University of Milan, Milan, Italy., Fondazione IRCCS Ca 39; Granda Ospedale Maggiore Policlinico, Milan, Italy., Genome Integrity and Structural Biology Laboratory, National Institute of Environmental Health Sciences, Research Triangle Park, NC, USA., Department of Biochemistry and Structural Biology, University of Texas Health San Antonio, San Antonio, TX, USA., Howard Hughes Medical Institute, University of Texas Health San Antonio, San Antonio, TX, USA., Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, MD, USA. landim@mail.nih.gov.,
    1. Year: 2025
    2. Date: May 21
    3. Epub Date: 2025 05 21
  2. Journal: Nature Communications
    1. 16
    2. 1
    3. Pages: 4711
  4. Type of Article: Article
  5. Article Number: 4711
  1. Abstract:

    Most solid tumors harbor somatic mutations attributed to off-target activities of APOBEC3A (A3A) and/or APOBEC3B (A3B). However, how APOBEC3A/B enzymes affect tumor evolution in the presence of exogenous mutagenic processes is largely unknown. Here, multi-omics profiling of 309 lung cancers from smokers identifies two subtypes defined by low (LAS) and high (HAS) APOBEC mutagenesis. LAS are enriched for A3B-like mutagenesis and KRAS mutations; HAS for A3A-like mutagenesis and TP53 mutations. Compared to LAS, HAS have older age at onset and high proportions of newly generated progenitor-like cells likely due to the combined tobacco smoking- and APOBEC3A-associated DNA damage and apoptosis. Consistently, HAS exhibit high expression of pulmonary healing signaling pathway, stemness markers, distal cell-of-origin, more neoantigens, slower clonal expansion, but no smoking-associated genomic/epigenomic changes. With validation in 184 lung tumor samples, these findings show how heterogeneity in mutational burden across co-occurring mutational processes and cell types contributes to tumor development. © 2025. This is a U.S. Government work and not under copyright protection in the US; foreign copyright protection may apply.

    See More

External Sources

  1. View Full Text
  2. DOI: 10.1038/s41467-025-59923-8
  3. PMID: 40394004
  4. PMCID: PMC12092836
  5. PII : 10.1038/s41467-025-59923-8

Library Notes

  1. Fiscal Year: FY2024-2025
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel